Renal rehabilitation with low-dialysate-flow daily hemodialysis for people on hemodialysis
Official title: Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate.
Run by Brugmann University Hospital · NCT07413315 · Data updated 2026-11-12
This tests whether combining a tailored rehab program (exercise + nutrition) with low-dialysate-flow daily hemodialysis helps people on hemodialysis who are at risk of muscle loss (sarcopenia).
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Brugmann University Hospital Academic / other |
| Locations | 1 site (Brussels) |
| Status | Recruiting |
| Started | August 13, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT07413315 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with end-stage CKD who require ongoing hemodialysis and are recently hospitalized but medically stable without major cardiac, cognitive, or neurologic contraindications.
✕Probably not a fit
Patients with significant cognitive impairment, unstable or severe cardiac disease, certain acute infections or inflammatory cardiac conditions, pregnancy, recovery of kidney function, or recent spinal cord injury are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program pairs a multidisciplinary renal rehabilitation plan (structured physical exercise and nutritional monitoring) with low-dialysate-flow hemodialysis delivered more frequently. It targets patients with end-stage chronic kidney disease on hemodialysis, a group with high rates of sarcopenia and post-dialysis symptoms. Eligible participants are recently hospitalized but must be medically stable and free of major cognitive, cardiac, or neurologic contraindications. The study site is CHU Brugmann in Brussels and outcomes are expected to include changes in muscle mass, functional capacity, and dialysis tolerance.
Why it matters
Potential benefit: If successful, the approach could improve muscle strength and physical function, reduce post-dialysis symptoms, and improve quality of life for people on hemodialysis.
How similar studies have gone: Previous work on intradialytic exercise and multidisciplinary renal rehabilitation has shown improvements in physical function and sarcopenia in dialysis populations, though combining these programs with low-dialysate-flow daily hemodialysis is less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient with terminal chronic kidney disease requiring hemodialysis treatment * patient recently hospitalized for an acute medical event. Exclusion Criteria: * dementia/mild cognitive impairment (MMSE \< 20/30) * decompensated psychiatric pathology and/or behavioral disorders * pregnant woman * recovery of renal function allowing interruption of helodialysis sessions * candidate for neurological rehabilitation * patient with recent spinal cord injury * patient with absolute and/or relative contraindication to performing a stress test * severe or poorly tolerated cardiac rhythm disorder * severe or symptomatic obstruction to left ventricular ejection * decompensated heart failure * acute myocarditis, pericarditis or endocarditis * acute aortic dissection * high-risk emboligenic intracardiac thrombus * significant stenosis of the common trunk * ventricular aneurysm * supraventricular tachycardia with poorly controlled ventricular rate, acquired high-degree or complete block * obstructive cardiomyopathy with high resting gradient * recent stroke or TIA * acute venous thrombosis with or without pulmonary embolism * poorly controlled clinical condition, such as marked anemia, significant electrolyte disturbance, hyperthyroidism, etc. * lack of cooperation from the patient * Blood pressure \> 200/110 mmHg
Where it's running
-
CHU Brugmann
Brussels, Belgium Recruiting
Study contacts
- Principal investigator: Joris Vanparys, MD — CHU Brugmann
- Study coordinator: Joris Vanparys, MD
- Email: Joris.VANPARYS@chu-brugmann.be
- Phone: +32 2475 52 64
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Lower-limb rehabilitation robot training with nutrition education for sarcopenia
In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.